“I was wrong.”The federal government has on hand nearly 532,000 doses of the two drugs, and 55 percent of that has been shipped out, according to the Department of Health and Human Services. But early data collected from hospitals by the federal government suggest that they have given only about 20 percent of their supply to patients. Administrators have struggled to identify people who should get the antibody drugs because of delays in testing and a lack of coordination between testing sites and hospitals. And demand from patients themselves has been weaker than expected. Federal and state health officials have had to take the extraordinary step of urging patients to seek out treatments that were once expected to be snatched up.

Source: New York Times December 23, 2020 15:22 UTC